Coverage dated March 21, 2022

Pfizer to supply UNICEF with nearly 4 million rounds of oral COVID treatment

Headline from The Hill

Pfizer has agreed to provide nearly 4 millions courses of its oral COVID-19 treatment to UNICEF to be used in 95 low- and middle-income countries.

The Hill's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Reports & sources

6 articles, oldest first.

The Hill
Pfizer to supply UNICEF with nearly 4 million rounds of oral COVID treatment (opens The Hill)
Published Mar 21, 2022
The Hill's feed description
Pfizer has agreed to provide nearly 4 millions courses of its oral COVID-19 treatment to UNICEF to be used in 95 low- and middle-income countries.
NBC Los Angeles
Pfizer to Supply 4 Million Covid Antiviral Treatments to Poorer Nations Through UNICEF (opens NBC Los Angeles)
Published Mar 21, 2022
NBC Los Angeles's feed description
Pfizer expects to start supplying the antiviral pills, Paxlovid, to UNICEF beginning next month and will continue to do so through the end of the year.
Washington Times
Pfizer to supply UNICEF with 4 million COVID-19 pills for poorer nations (opens Washington Times)
Published Mar 21, 2022
Washington Times's feed description
Pfizer said Tuesday it reached a deal with the humanitarian-aid branch of the U.N. to supply 4 million courses of its pills for COVID-19 to low- and middle-income countries, likely making them the first significant treatments available in poorer parts of the world.

Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.